Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with Ascentage Pharma Group Corporation, Ltd.
Appears in 7 contracts
Sources: Research Agreement, Research Agreement, Research Agreement
Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with Ascentage Pharma Group CorporationiReprogram, Ltd.LLC.
Appears in 3 contracts
Sources: Subcontract Agreement, Subcontract Agreement, Subcontract Agreement
Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with Ascentage Pharma Group CorporationATGC, Ltd.Inc.
Appears in 2 contracts
Sources: Subcontract Agreement, Subcontract Agreement
Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with Ascentage Pharma Group CorporationOpsidio, Ltd.Inc.
Appears in 1 contract
Sources: Subcontract Agreement
Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with Ascentage Pharma Group Corporationbetween the University and iReprogram, Ltd.LLC.
Appears in 1 contract
Sources: Option Agreement
Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with Ascentage Pharma Group Corporation, Ltd.Phenomics Health Inc.
Appears in 1 contract
Sources: Subcontract Agreement
Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into amending this Agreement with Ascentage Pharma Group Corporation, Ltd.
Appears in 1 contract
Sources: Research Agreement
Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with Ascentage Pharma Group CorporationOpsidio, Ltd.LLC.
Appears in 1 contract
Sources: Subcontract Agreement
Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with Ascentage Pharma Group Corporationbetween the University and CRIMSON, Ltd.LLC.
Appears in 1 contract
Sources: License Agreement
Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with Ascentage Pharma Group Corporationbetween the University and Angioaid, Ltd.Inc.
Appears in 1 contract
Sources: License Agreement
Recommendations. This matter has been reviewed and approved by the Medical School Conflict of Interest Board. In light of this disclosure and our finding that the Agreement was negotiated in conformance with standard University practices, I recommend that the Board of Regents approve the University’s entering into this Agreement with Ascentage Pharma Group Corporation, Ltd.EMPOWR-ME LLC dba HealthIntel LLC.
Appears in 1 contract
Sources: Research Agreement